Paradoxical intraocular pressure elevation after combined therapy with latanoprost and bimatoprost

Archives of Ophthalmology

Volumn 120, Issue 6, 2002, Pages 847-849

  Herndon, Leon W ^a   Asrani, Sanjay G ^a   Williams, Gayle H ^a   Challa, Pratap ^a   Lee, Paul P ^a  

^a DUKE UNIVERSITY EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIMATOPROST; BRIMONIDINE; DORZOLAMIDE; DORZOLAMIDE PLUS TIMOLOL; LATANOPROST; TIMOLOL MALEATE; UNOPROSTONE ISOPROPYL ESTER;

ADULT; AGED; ARTICLE; CASE REPORT; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; INTRAOCULAR PRESSURE ABNORMALITY; IRIDECTOMY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL;

AGED; AMIDES; ANTIHYPERTENSIVE AGENTS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; GLAUCOMA, ANGLE-CLOSURE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; LIPIDS; MALE; MIDDLE AGED; OCULAR HYPERTENSION; PROSTAGLANDINS F, SYNTHETIC;

EID: 0036276217     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning: A comparison with timolol
2. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: A six-month, masked, multicenter trial in the United States
3. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertention
4. A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension
5. PhXA34, a new potent ocular hypotensive drug: A study on dose-response relationship and on aqueous humor dynamics in healthy volunteers
6. 2α analogue, after topical application in normal and ocular hypertensive human eyes
7. Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure
8. Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP: A 3-month clinical trial
9. Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics
10. Systemic effects of medications used to treat glaucoma
11. The Advanced Glaucoma Intervention Study (AGIS), 7: The relationship between control of intraocular pressure and visual field deterioration
12. Comparison of glaucomatous progression between untreated patients with normaltension glaucoma and patients with therapeutically reduced intraocular pressures
13. The pharmacology of bimatoprost (Bimatoprost)
14. Intraocular pressure-reducing effect of PhXA41 in patients with increased eye pressure: A one-month study
15. Intraocular pressure-reducing effect of PhXA41 in ocular hypertension: Comparison of dose regimens
16. Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol
17. Latanoprost twice daily is less effective than once daily: Indication of receptor subsensitivity?
18. 2α
19. 2α
20. Additive efficacy of unoprostone isopropyl 0.12% to latanoprost 0.005%